Breaking News, Collaborations & Alliances

Harbour BioMed, Chia Tai Tianqing Enter Biologics Partnership

Global collaboration focused on new antibody treatments in the fields of oncology and immunology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Harbour BioMed and Chia Tai Tianqing Pharmaceutical (CTTQ) are entering into a strategic alliance to discover, develop and commercialize next-generation biologics for multiple therapeutic targets in oncology and immunology.   The collaboration will combine Harbour BioMed’s discovery capabilities, including its transgenic mouse technologies for generating fully human antibodies, with CTTQ’s preclinical development resources and expertise. The companies will be responsible for clinic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters